Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy
Status:
Completed
Trial end date:
2009-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and
effective in reducing the amount of narcotic pain medication needed to control pain during
the first 24 hours after herniorrhaphy.